Inventor · disambiguated record
Friedrich Metzger
Also filed as: METZGER FRIEDRICH
7 granted patents·22 pending applications·29 citations·filing 2005–2024
80Inventor score
Top patents by PatentIndex Score
29 records- 0189US7625996B2Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)HOFFMANN LA ROCHE·Filed 2007·Granted Dec 1, 2009·14 cites·9 claims
- 0288US9956223B2Screening methodHOFFMANN LA ROCHE·Filed 2016·Granted May 1, 2018·14 cites·9 claims
- 0375US11938136B2Compositions for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2019·Granted Mar 26, 2024·1 cites·47 claims
- 0470US2024293410A1Compositions for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0565US2010035817A1Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)FISCHER STEPHAN·Filed 2009·Application pending·0 cites
- 0663US11066400B2Compounds for the treatment of cancerHOFFMANN LA ROCHE·Filed 2017·Granted Jul 20, 2021·0 cites·20 claims
- 0762US9724425B2Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)HOFFMANN LA ROCHE·Filed 2014·Granted Aug 8, 2017·0 cites·6 claims
- 0859US2024358704A1Combined administrationHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0957US8476232B2Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)FISCHER STEPHAN·Filed 2012·Granted Jul 2, 2013·0 cites·1 claims
- 1057US2024117361A1Compositions and methods for modulating expression of genesVERSAMEB AG·Filed 2023·Application pending·0 cites
- 1157US2024117354A1Compositions and methods for modulating expression of genesVERSAMEB AG·Filed 2023·Application pending·0 cites
- 1256US2013217623A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)HOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1353US2009253628A1Use of PEGylated IGF-I variants for the treatment of neuromuscular disordersHOLTMANN BETTINA·Filed 2009·Application pending·0 cites
- 1453US2024108693A1Method of treating lower urinary tract symptomsVERSAMEB AG·Filed 2023·Application pending·0 cites
- 1553US2012322732A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2012·Application pending·0 cites
- 1653US2006154865A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2005·Application pending·0 cites
- 1752US2017001995A1Compounds for the treatment of cancerHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1852US2023322885A1Compositions and methods for simultaneously modulating expression of genesVERSAMEB AG·Filed 2023·Application pending·0 cites
- 1951US10702530B2Screening methodHOFFMANN LA ROCHE·Filed 2018·Granted Jul 7, 2020·0 cites·8 claims
- 2049US2010210547A1Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)FISCHER STEPHAN·Filed 2010·Application pending·0 cites
- 2149US2014073567A1Use of pegylated igf-1 variants for the treatment of neuromuscular disordersHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2248US2022389423A1Compositions and Methods for Simultaneously Modulating Expression of GenesVERSAMEB AG·Filed 2022·Application pending·0 cites
- 2348US2011009317A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2010·Application pending·0 cites
- 2447US2017014488A1Use of pegylated igf-1 variants for the treatment of neuromuscular disordersHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2546US2018289712A1Compositions for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2646US2022002364A1Rna encoding a proteinVERSAMEB AG·Filed 2021·Application pending·0 cites
- 2743US2015273023A1Use of PEGylated IGF-I Variants For The Treatment Of Neuromuscular DisordersHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2842US2018289713A1Compounds for treating amyotrophic lateral sclerosisHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2941US2011183903A1USE OF PEGylated IGF-I VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERSHOLTMANN BETTINA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Friedrich Metzger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →